Differences between subjective and objective assessments of the utility of Electroconvulsive therapy in patients with bipolar and unipolar depression

Journal of Affective Disorders

Volumn 112, Issue 1-3, 2009, Pages 212-218

  Hallam, K T ^a,b,c,d   Smith, D I ^a   Berk, M ^c,d,e,f  

^a RMIT UNIVERSITY   (Australia)

^b VICTORIA UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ORYGEN RESEARCH CENTRE   (Australia)

^e BARWON HEALTH   (Australia)

^f FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Bipolar disorder; Clinician rated; Depression; Electroconvulsive therapy; Outcomes; Self report

Indexed keywords

ADULT; ARTICLE; BIPOLAR DEPRESSION; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; FEMALE; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL RECORD; PRIORITY JOURNAL; SELF REPORT; TREATMENT OUTCOME;

ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; BIPOLAR DISORDER; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ELECTROCONVULSIVE THERAPY; FEMALE; HEALTH STATUS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHIATRY; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME; VICTORIA;

EID: 56249131097     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.03.024     Document Type: Article

References (47)

1. Access Economics for SANE Australia. Bipolar Disorder: Costs: An Analysis of the Burden of Bipolar Disorder and Related Suicide in Australia. Melbourne (2003)
2. Altshuler L.L., Post R.M., Leverich G.S., Mikalauskas K., Rosoff A., and Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. American Journal of Psychiatry 152 8 (1995) 1130-1138
3. Bailey J., and Coppen A. A comparison between the Hamilton Depression Rating Scale and the Beck Inventory in the measurement of depression. British Journal of Psychiatry 128 (1976) 486-489
4. Berk M., Ng F., Dodd S., Callaly T., Campbell S., Bernardo M., and Trauer T. The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use. Journal of Evaluation in Clinical Practice 14 6 (2008) 979-983
5. Bowden C.L., Calabrese J.R., Sachs G., Yatham L.N., Asghar S.A., Hompland M., Montgomery P., Earl N., Smoot T.M., DeVeaugh-Geiss J., and Lamictal 606 Study G. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Archives of General Psychiatry 60 (2003) 392-400
6. Britto de Marcedo-Soares M., Moreno R.A., Rigonatti S.P., and Lafer B. Efficacy of electroconvulsive therapy in treament resistant bipolar disorders. Journal of ECT 21 (2005) 31-34
7. Brooks R. The reliability and validity of the Health of the Nation Outcome Scales: validation in relation to patient derived measures. Australian and New Zealand Journal of Psychiatry 34 3 (2000) 504-511 discussion 520-1
8. Brown T.A., Chorpita B.F., Korotitsch W., and Barlow D.H. Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples. Behaviour Research and Therapy 35 1 (1997) 79-89
9. Bunney W.E., and Hamburg D.A. Methods for reliable longitudinal observation of behaviour. Archives of General Psychiatry 9 (1963) 280-294
10. Calabrese J.R., Suppes T., Bowden C.L., Sachs G.S., Swann A.C., McElroy S.L., Kusumakar V., Ascher J.A., Earl N.L., Greene P.L., and Monaghan E.T. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. Journal of Clinical Psychiatry 61 (2000) 841-850
11. Calabrese J.R., Shelton M.D., Rapport D.J., Kimmel S.E., and Elhaj O. Long-term treatment of bipolar disorder with lamotrigine. Journal of Clinical Psychiatry 63 Suppl 10 (2002) 18-22
12. Calabrese J.R., Bowden C.L., and Sachs G.S. A placebo-controlled 18-month trial of lamotregine and lithium maintenance treatment in recently depressed patients with bipolar disorder. Journal of Clinical Psychiatry 64 (2003) 1013-1024
13. Calabrese J.R., Keck Jr. P.E., Macfadden W., Minkwitz M., Ketter T.A., Weisler R.H., Cutler A.J., McCoy R., Wilson E., Mullen J., and The B.S.G. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. American Journal of Psychiatry 162 7 (2005) 1351-1360
14. Ciapparelli A., Dell'Osso L., Tundo A., Pini S., Chiavacci M.C., DiSacco I., and Cassano G.B. Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression. Journal of Clinical Psychiatry 62 (2001) 552-555
15. Daly J.J., Prudic J., Devanand D.P., Nobler M.S., Lisanby S.H., Peyser S., Roose S.P., and Sackeim H.A. ECT in bipolar and unipolar depression: differences in speed of response. Bipolar Disorders 3 (2001) 95-104
16. Devanand D.P., Polanco P., Cruz R., Shah S., Paykina N., Singh K., and Majors L. The efficacy of ECT in mixed affective states. Journal of ECT 16 (2000) 32-37
17. Fisher L.J., Goldney R.D., Furze P.F., Williams J.L., Mattner J., and McCleave D.J. Electroconvulsive therapy, depression, and cognitive outcomes: an Australian audit. Journal of ECT 20 (2004) 174-178
18. Ghaemi S.N., Hsu D.J., Soldani F., and Goodwin F.K. Antidepressants in bipolar disorder: the case for caution. Bipolar Disorders 5 (2003) 421-433
19. Goldberg J.F., and Truman C.J. Antidepressant-induced mania: an overview of current controversies. Bipolar Disorders 5 6 (2003) 407-420
20. Goodwin F.K., and Jamison K.R. Manic-depressive Illness: Bipolar Disorder and Recurrent Depression (2007), Oxford University Press, New York
21. Grunhaus L., Schreiber S., Dolberg O.T., Hirshman S., and Dannon P.N. Response to ECT in major depression: are there differences between unipolar and bipolar depression?. Bipolar Disorders 4 (2002) 91-93
22. Grunze H. Reevaluating therapies for bipolar depression. Journal of Clinical Psychiatry 66 (2005) 17-25
23. Henry J.D., and Crawford J.R. The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample. British Journal of Clinical Psychology 44 Pt 2 (2005) 227-239
24. Jenkinson C., Wright L., and Coulter A. Criterion validity and reliability of the SF-36 in a population sample. Quality of Life Research 3 1 (1994) 7-12
25. Kellner C.H., Fink M., Knapp R., Petrides G., Husain M., Rummans T., Mueller M., Bernstein H., Rasmussen K., O'Connor K., Smith G., Rush A.J., Biggs M., McClintock S., Bailine S., and Malur C. Relief of expressed suicidal intent by ECT: A consortium for research in ECT study. American Journal of Psychiatry 162 (2005) 977-982
26. Kho K.H., Zwinderman A.H., and Blansjaar B.A. Predictors for the efficacy of electroconvulsive therapy: chart review of a naturalistic study. Journal of Clinical Psychiatry 66 (2005) 894-899
27. Kushmaker V., and Yatham L. An open study of lamotrigine in refractory bipolar depression. Psychiatry Research 72 (1997) 145-148
28. Leidy N.K., Palmer C., Murray M., Robb J., and Revicki D.A. Health-related quality of life assessment in euthymic and depressed patients with bipolar disorder. Psychometric performance of four self-report measures. Journal of Affective Disorders 48 2-3 (1998) 207-214
29. Maletzky B.M. The first-line use of electroconvulsive therapy in major affective disorders. Journal of ECT 20 (2004) 112-117
30. McCall W.V., Reboussin D.M., Weiner R.D., and Sackeim H.A. Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Archives of General Psychiatry 57 (2000) 438-444
31. McHorney C.A., Ware Jr. J.E., Lu J.F., and Sherbourne C.D. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care 32 1 (1994) 40-66
32. Mitchell P.B., and Malhi G.S. The expanding pharmacopoeia for bipolar disorder. Annual Review of Medicine 53 (2002) 173-188
33. Moller H.J. Rating depressed patients: observer- vs self-assessment. European Psychiatry 15 (2000) 160-172
34. Ng F., Trauer T., Dodd S., Callaly T., Campbell S., and Berk M. The validity of the 21-item version of the Depression Anxiety Stress Scales as a routine clinical outcome measure. Acta Neuropsychiatrica 19 (2007) 304-310
35. Page A.C., Hooke G.R., and Rutherford E.M. Measuring mental health outcomes in a private psychiatric clinic: Health of the Nation Outcome Scales and Medical Outcomes Short Form SF-36. Australian and New Zealand Journal of Psychiatry 35 3 (2001) 377-381
36. Page A.C., Hooke G.R., and Morrison D.L. Psychometric properties of the Depression Anxiety Stress Scales (DASS) in depressed clinical samples. British Journal of Clinical Psychology 46 Pt 3 (2007) 283-297
37. Post R.M., Altshuler L., Frye M.A., Suppes T., Rush A.J., Keck P.E., McElroy S.L., Denicoff K.D., Leverich G.S., Kupka R., and Nolen W.A. Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. Bipolar Disorders 3 (2001) 259-265
38. Prusoff B.A., Klerman G.L., and Paykel E.S. Pitfalls in the self-report assessment of depression. Canadian Psychiatric Association Journal 17 2 (1972) SS101 Suppl 2
39. Sachs G.S., Nierenberg A.A., Calabrese J.R., Marangell L.B., Wisniewski S.R., Gyulai L., Friedman E.S., Bowden C.L., Fossey M.D., Ostacher M.J., Ketter T.A., Patel J., Hauser P., Rapport D., Martinez J.M., Allen M.H., Miklowitz D.J., Otto M.W., Dennehy E.B., and Thase M.E. Effectiveness of adjunctive antidepressant treatment for bipolar depression. New England Journal Of Medicine 356 17 (2007) 1711-1722
40. Sackeim H.A., and Prudic J. Length of ECT course in bipolar and unipolar depression. Journal of ECT 21 (2005) 195-197
41. Sackeim H.A., Prudic J., Devanand D.P., Kiersky J.E., Fitzsimons L., Moody B.J., McElhiney M.C., Coleman E.A., and Settembrino J.M. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. New England Journal of Medicine 328 12 (1993) 839-846
42. Sackeim H.A., Prudic J., Devanand D.P., Nobler M.S., Lisanby S.H., Peyser S., Fitzsimons L., Moody B.J., and Clark J. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Archives of General Psychiatry 57 5 (2000) 425-434
43. Sprangers M.A., and Aaronson N.K. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. Journal of Clinical Epidemiology 45 7 (1992) 743-760
44. Tohen M., Vieta E., Calabrese J., Ketter T.A., Sachs G., Bowden C.L., Mitchell P.B., Centorrino F., Risser R., Baker R.W., Evans A.R., Beymer K., Dube S., Tollefson G.A., and Breier A. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Archives of General Psychiatry 60 (2003) 1079-1088
45. Yatham L.N., Lecrubier Y., Fieve R.R., Davis K.H., Harris S.D., and Krishnan A.A. Quality of life in patients with bipolar I depression: data from 920 patients. Bipolar Disorder 6 5 (2004) 379-385
46. Zornberg G.L., and Pope H.G. Treatment of depression in bipolar disorder: new directions for research. Journal of Clinical Psychopharmacology 13 (1993) 397-408
47. Zorumski C.F., Rutherford J.L., Burke W.J., and Reich T. ECT in primary and secondary depression. Journal of Clinical Psychiatry 47 (1986) 298-300